Quest Diagnostics Incorporated (DGX)
NYSE: DGX · IEX Real-Time Price · USD
136.64
-0.45 (-0.33%)
At close: Jul 2, 2024, 4:00 PM
137.62
+0.98 (0.72%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Quest Diagnostics stock have an average target of 148.25, with a low estimate of 135 and a high estimate of 160. The average target predicts an increase of 8.50% from the current stock price of 136.64.
Analyst Consensus: Buy
* Price targets were last updated on May 30, 2024.
Analyst Ratings
The average analyst rating for DGX stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 10 | 7 | 7 | 8 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 10 | 9 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $152 → $155 | Hold | Maintains | $152 → $155 | +13.44% | May 30, 2024 |
| Barclays | Barclays | Hold Maintains $138 → $144 | Hold | Maintains | $138 → $144 | +5.39% | Apr 25, 2024 |
| Citigroup | Citigroup | Hold Maintains $135 → $145 | Hold | Maintains | $135 → $145 | +6.12% | Apr 24, 2024 |
| UBS | UBS | Hold Maintains $139 → $146 | Hold | Maintains | $139 → $146 | +6.85% | Apr 24, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $145 → $150 | Hold | Maintains | $145 → $150 | +9.78% | Apr 24, 2024 |
Financial Forecast
Revenue This Year
9.54B
from 9.25B
Increased by 3.13%
Revenue Next Year
9.86B
from 9.54B
Increased by 3.37%
EPS This Year
8.92
from 7.49
Increased by 19.07%
EPS Next Year
9.56
from 8.92
Increased by 7.23%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.0B | 10.4B | 10.8B | 11.0B | 11.4B |
| Avg | 9.5B | 9.9B | 10.2B | 10.3B | 10.5B |
| Low | 9.2B | 9.4B | 9.5B | 9.6B | 9.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.6% | 9.1% | 9.6% | 7.8% | 11.3% |
| Avg | 3.1% | 3.4% | 3.6% | 0.4% | 2.6% |
| Low | -0.3% | -2.0% | -3.8% | -5.8% | -4.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.41 | 10.20 | 11.12 | 11.53 | 12.57 |
| Avg | 8.92 | 9.56 | 10.33 | 11.05 | 11.99 |
| Low | 8.20 | 9.05 | 9.77 | 10.68 | 11.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.6% | 14.3% | 16.3% | 11.6% | 13.7% |
| Avg | 19.1% | 7.2% | 8.0% | 7.0% | 8.5% |
| Low | 9.5% | 1.4% | 2.2% | 3.4% | 4.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.